Target intelligence / Profile preview

HOX transcript antisense RNA (HOTAIR)

Target
HOTAIR
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

HOX transcript antisense RNA (HOTAIR) is a 2,148-nucleotide long human long non-coding RNA (lncRNA) transcribed from the HOXC locus on chromosome 12[3]. It is best known for its role in regulating chromatin structure and gene expression via trans-acting epigenetic silencing: HOTAIR binds Polycomb Repressive Complex 2 (PRC2) through its 5'-domain and LSD1/CoREST/REST through its 3'-domain, enabling it to guide these complexes to the HOXD locus (chromosome 2) and repress gene transcription[1][3]. HOTAIR is implicated in physiological processes such as epidermal and bone development, as well as in the pathogenesis of many cancers, where its high expression correlates with metastasis, poor prognosis, and increased invasiveness. It can also act as a competing endogenous RNA (ceRNA) in cytoplasm, binding miRNAs such as miR-214 to modulate differentiation[2]. As a lncRNA, HOTAIR does not encode a protein and is distinguished by its stable, modular secondary structure essential for interactions with chromatin-modifying enzymes and regulatory proteins[1][4]. No drugs currently target HOTAIR directly in clinical practice, but it is viewed as a promising therapeutic target and biomarker in oncology and bone metabolism due to its critical role in epigenetic gene regulation[5].

Other names
HOXC-AS4HOXC11-AS1NCRNA00072HOXC cluster antisense RNA 4 (non-protein coding)non-protein coding RNA 72HOXAShox transcript antisense intergenic RNA
02

Mechanism of action

Inhibition of HOTAIR function (via antisense oligonucleotides or RNA interference) aims to block epigenetic gene silencing and tumor progression; experimental approaches seek to disrupt HOTAIR–PRC2 or HOTAIR–LSD1 interactions[1][4][5]

03

Biological functions

Epigenetic regulationTranscriptional repressionChromatin remodelingCell proliferationRegulation of differentiationModulation of cell invasion/metastasisOther
04

Disease associations

CancerBone diseasesOther
05

Safety considerations

Targeting lncRNAs like HOTAIR may lack tissue specificity, potentially affecting normal chromatin regulation and developmentOff-target effects or immune responses possible[5]
06

Interacting drugs

None conclusively validated; ongoing research into antisense oligonucleotides, small molecule inhibitors, and RNA-targeted therapeutics, but no approved drugs directly target HOTAIR[5]
07

Biomarkers

HOTAIR expression serves as a biomarker for poor prognosis in multiple cancers (including breast, colorectal, and hepatocellular carcinoma)[5]HOTAIR expression serves as a biomarker for bone metabolic conditions[2]

Beyond the preview

Go deeper on HOX transcript antisense RNA (HOTAIR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HOX transcript antisense RNA (HOTAIR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call